Many companies remain quiet on how they will adjust to the device excise tax scheduled to go into effect Jan. 1. But some firms have started to reveal strategies to either soften its blow or to capitalize on its implications.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?